These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12193226)

  • 1. Dendritic cells present an intracellular viral antigen derived from apoptotic cells and induce a T-cell response.
    Van Zanten J; Hospers GA; Harmsen MC; The TH; Mulder NH; De Leij LF
    Scand J Immunol; 2002 Sep; 56(3):254-9. PubMed ID: 12193226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells.
    Arrode G; Boccaccio C; Lulé J; Allart S; Moinard N; Abastado JP; Alam A; Davrinche C
    J Virol; 2000 Nov; 74(21):10018-24. PubMed ID: 11024130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
    Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
    Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
    Forsberg O; Carlsson B; Tötterman TH; Essand M
    Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide.
    Einsele H; Rauser G; Grigoleit U; Hebart H; Sinzger C; Riegler S; Jahn G
    Cytotherapy; 2002; 4(1):49-54. PubMed ID: 11953041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells.
    Bonini C; Lee SP; Riddell SR; Greenberg PD
    J Immunol; 2001 Apr; 166(8):5250-7. PubMed ID: 11290810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
    Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
    J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.
    Arrode G; Boccaccio C; Abastado JP; Davrinche C
    J Virol; 2002 Jan; 76(1):142-50. PubMed ID: 11739680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response.
    Feuchtinger T; Opherk K; Bicanic O; Schumm M; Grigoleit GU; Hamprecht K; Jahn G; Handgretinger R; Lang P
    Cytotherapy; 2010 Nov; 12(7):945-50. PubMed ID: 20230226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Function and Maturation of Dendritic Cells Stimulated by Recombinant pp65 Protein: An in-vitro Design.
    Nikmanesh Y; Karimi MH; Yaghobi R; Marashi SM; Mahmoudi M; Moravej A; Shahmahmoodi S
    Iran J Immunol; 2019 Mar; 16(1):11-25. PubMed ID: 30864552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
    Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
    J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein.
    Carlsson B; Hou M; Giandomenico V; Nilsson B; Totterman TH; Essand M
    J Infect Dis; 2005 Dec; 192(11):1912-20. PubMed ID: 16267762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells cross-talk with tumour antigen-specific CD8
    Eiraku Y; Terunuma H; Yagi M; Deng X; Nicol AJ; Nieda M
    Clin Exp Immunol; 2018 Oct; 194(1):54-66. PubMed ID: 30009488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast.
    Breinig F; Heintel T; Schumacher A; Meyerhans A; Schmitt MJ
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):231-9. PubMed ID: 14522458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.
    Flinsenberg TW; Spel L; Jansen M; Koning D; de Haar C; Plantinga M; Scholman R; van Loenen MM; Nierkens S; Boon L; van Baarle D; Heemskerk MH; Boelens JJ; Boes M
    J Virol; 2015 Jan; 89(2):1058-69. PubMed ID: 25378489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of the Human Cytomegalovirus pp65 antigen with both ubiquitin and ornithine decarboxylase additively enhances antigen presentation to CD8(+) T cells in human dendritic cells.
    Park MJ; Kim EK; Han JY; Cho HW; Sohn HJ; Kim SY; Kim TG
    Hum Gene Ther; 2010 Aug; 21(8):957-67. PubMed ID: 20218861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.